Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,765 | 1,035 | 44.9% |
| Consulting Fee | $12,324 | 4 | 29.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,292 | 28 | 19.9% |
| Travel and Lodging | $2,300 | 6 | 5.5% |
| Education | $85.97 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $12,831 | 42 | $0 (2024) |
| GENZYME CORPORATION | $7,814 | 35 | $0 (2023) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $5,390 | 66 | $0 (2024) |
| Biogen, Inc. | $1,408 | 95 | $0 (2024) |
| EMD Serono, Inc. | $1,189 | 48 | $0 (2024) |
| Amgen Inc. | $1,020 | 64 | $0 (2024) |
| UCB, Inc. | $848.35 | 40 | $0 (2024) |
| Celgene Corporation | $779.52 | 32 | $0 (2024) |
| ABBVIE INC. | $726.93 | 70 | $0 (2024) |
| Acorda Therapeutics, Inc | $567.10 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,017 | 185 | Neurocrine Biosciences, Inc. ($476.26) |
| 2023 | $10,444 | 163 | GENZYME CORPORATION ($7,308) |
| 2022 | $1,340 | 86 | EMD Serono, Inc. ($155.47) |
| 2021 | $1,004 | 80 | AbbVie Inc. ($234.32) |
| 2020 | $2,363 | 62 | Alexion Pharmaceuticals, Inc. ($1,260) |
| 2019 | $17,931 | 168 | Alexion Pharmaceuticals, Inc. ($10,802) |
| 2018 | $2,461 | 167 | Mitsubishi Tanabe Pharma America, Inc. ($254.00) |
| 2017 | $2,207 | 170 | GENZYME CORPORATION ($220.77) |
All Payment Transactions
1,081 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neurology | ||||||
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: PAIN | ||||||
| 12/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $116.66 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 229 | 387 | $134,956 | $31,223 |
| 2022 | 5 | 286 | 433 | $94,378 | $37,076 |
| 2021 | 5 | 411 | 528 | $101,620 | $42,617 |
| 2020 | 4 | 467 | 674 | $128,110 | $43,936 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 317 | $109,160 | $24,095 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,552 | $3,808 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 32 | $14,244 | $3,320 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 272 | $57,546 | $24,119 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 41 | $11,439 | $4,818 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $11,618 | $4,177 | 36.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 53 | $9,275 | $2,951 | 31.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 25 | 30 | $4,500 | $1,010 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 267 | $58,469 | $22,734 | 38.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 113 | 144 | $18,305 | $8,733 | 47.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $13,512 | $6,165 | 45.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 29 | $6,726 | $3,581 | 53.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 33 | 38 | $4,608 | $1,404 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 245 | 414 | $91,080 | $28,628 | 31.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 198 | $23,840 | $9,114 | 38.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $10,000 | $4,719 | 47.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $3,190 | $1,475 | 46.3% |
About Dr. John Riser, MD
Dr. John Riser, MD is a Specialist healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134216088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Riser, MD has received a total of $41,767 in payments from pharmaceutical and medical device companies, with $4,017 received in 2024. These payments were reported across 1,081 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($18,765).
As a Medicare-enrolled provider, Riser has provided services to 1,393 Medicare beneficiaries, totaling 2,022 services with total Medicare billing of $154,852. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Birmingham, AL
- Active Since 10/10/2006
- Last Updated 08/16/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1134216088
Products in Payments
- SOLIRIS (Drug) $6,982
- RADICAVA (Drug) $3,605
- Radicava (Drug) $1,785
- TYSABRI (Biological) $1,141
- Aimovig (Biological) $687.16
- ZEPOSIA (Drug) $637.53
- ACTHAR (Biological) $530.97
- NURTEC ODT (Drug) $517.24
- BRIUMVI (Drug) $502.94
- INGREZZA (Drug) $476.26
- EMGALITY (Drug) $451.28
- UBRELVY (Drug) $390.33
- INBRIJA (Drug) $390.00
- ULTOMIRIS (Biological) $378.16
- Betaseron (Drug) $351.75
- NUPLAZID (Drug) $347.72
- AUBAGIO (Drug) $314.58
- Ocrevus (Biological) $314.53
- VYVGART HYTRULO (Drug) $293.98
- MAVENCLAD (Drug) $285.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Birmingham
Dr. Weily Soong, M.d, M.D
Specialist — Payments: $920,269
Mrs. Emily Riser, Md, MD
Specialist — Payments: $372,369
Dr. Pamela Mclain, M.d, M.D
Specialist — Payments: $340,290
Dr. Michael Sillers, Md, MD
Specialist — Payments: $286,019
Jason Thompson, M.d, M.D
Specialist — Payments: $228,177
Dr. Stanley Hewlett, Md, MD
Specialist — Payments: $116,582